Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2009
10/14/2009CN101558072A Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors
10/14/2009CN101558048A Amino quinazolines derivatives wuth blood platelet reducing properties
10/14/2009CN101555274A Preparation method of polypeptide solid-phase synthesis bivalirudin crude product
10/14/2009CN101555204A Preparation method of caffeic acid medicinal raw material
10/14/2009CN101554467A Oral drug for removing edema
10/14/2009CN101554399A Psoralea corylifolial extract with immunologic enhancement and application thereof
10/14/2009CN101554382A New purpose of triterpene substance
10/14/2009CN101554379A Pharmaceutical composition containing clopidogrel
10/14/2009CN101554378A Pharmaceutical composition containing prasugrel
10/14/2009CN101554377A Pharmaceutical composition containing prasugrel and carbazochrome sodium sulfonate
10/14/2009CN101554375A Pharmaceutical composition containing clopidogrel and carbazochrome sodium sulfonate
10/14/2009CN101554373A Caffeic acid composition and preparation method thereof
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549005C Optically active dihydropyridine derivative
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548360C Medicament for promoting diuresis and diminishing inflammation and preparation process thereof
10/14/2009CN100548304C The use of cocoa procyanidins combined with acetylsalic acid as an anti-platelet therapy
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548297C Slow release drop pills comprising toraesmide active ingredient and method for preparing same
10/13/2009US7601746 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601515 Process of high purity albumin production
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/08/2009WO2009124103A2 Combination therapies comprising par1 antagonists with par4 antagonists
10/08/2009WO2009123573A1 Anticoagulants derived from naja nigricollis snake venom
10/08/2009WO2009123364A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123210A1 Preventive and/or remedy for vascular diseases
10/08/2009WO2009123162A1 Method for determination of edema associated with liver disease
10/08/2009WO2009123029A1 Blood ammonia level regulator
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009094456A3 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
10/08/2009WO2009027056A4 Antioxidant and paramagnetic heparin-nitroxide derivatives
10/08/2009US20090253766 Thiophene derivatives as factor xia inhibitors
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090252726 Antibodies for inhibiting blood coagulation and methods of use thereof
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720278A1 Agent for preventing and/or treating vascular diseases
10/08/2009CA2720011A1 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/07/2009EP1501493B1 Use of epa and dha in secondary prevention of strokes
10/07/2009EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009CN101553491A Quinoxaline derivative
10/07/2009CN101553475A Hydroxamates as inhibitors of histone deacetylase
10/07/2009CN101553466A New crystalline forms
10/07/2009CN101553226A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/07/2009CN101550115A Novel substituted piperazinyl alkoxy bibenzyl compound, preparation method and medical application thereof
10/07/2009CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009CN101549150A Application of prourokinase and prourokinase mutant in acute myocardial infarction facilitated percutaneous coronary artery intervention
10/07/2009CN101549146A Romurtide injection and preparation method thereof
10/07/2009CN101549133A Ablation and embolism extinguishing preparation of Chinese medicine
10/07/2009CN101549106A Traditional Chinese medicine with special efficacy for cerebral thrombosis and preparation method thereof
10/07/2009CN101549073A Medicament for treating idiopathic edema and preparation method thereof
10/07/2009CN101549066A Prescription for treating allergy purpura and method for preparing same
10/07/2009CN101549064A Medicament composition containing chilopod acting on NEI network and uses thereof
10/07/2009CN101549035A Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof
10/07/2009CN101549027A Shenqiningxue pill
10/07/2009CN101549021A Method for testing quality of perfoliate knotweed medicinal materials
10/07/2009CN101549010A A preparing method and application of malaytea scurfpea fruit total glycosides extract
10/07/2009CN101549005A Application of Acacia catechu (L.) wild extract to medicines capable of improving white blood cells
10/07/2009CN101548997A Application of medicament acting on NEI network for preparing medicine for curing vas pathological changes
10/07/2009CN101548984A Medicine liquor prepared by multi-medicine for exciting hematopoiesis functional and application for treating hematopathy
10/07/2009CN101548768A Health care wine and preparation method thereof
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009CN100546645C Medicine for preventing and treating fowl's ascites and preparing method
10/07/2009CN100546598C Oral liquid for eliminating dropsy and improving kidney function
10/07/2009CN100546577C Medical use for silybum or its salt
10/06/2009US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
10/06/2009US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009US7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
10/06/2009US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009US7598241 Carboxamide derivatives and their use as factor Xa inhibitors
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009US7597875 Diaminedioxime radiometal complexes
10/06/2009CA2453592C Dry hemostatic compositions and methods for their preparation
10/06/2009CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009WO2009120396A2 Compositions and methods for regulating erythropoientin expression and ameliorating anemia and stimulating erythropoiesis
10/01/2009WO2009119537A1 Hydroxyquinoxalinecarboxamide derivative
10/01/2009WO2009119105A1 METHOD FOR IN VITRO PREPARATION OF GPIbα+GPV+GPVI+ PLATELET
10/01/2009WO2009097973A3 Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments
10/01/2009WO2009082449A3 Resuscitation fluid
10/01/2009WO2009079401A3 Compositions and methods for increasing iron absorption
10/01/2009WO2007127377A8 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
10/01/2009US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension
10/01/2009US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses
10/01/2009US20090247459 Modified recombinant factor viii and von willebrand factor and methods of use
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247453 Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof
10/01/2009US20090246275 Compositions and methods for delivery of embolics
10/01/2009US20090246261 Fibrin foam and process for making
10/01/2009US20090246201 Substances